ABIVAX Societe Anonyme [ABVX] Securities Class Action Lawsuit Update

Company: ABIVAX Societe Anonyme

Ticker: (NASDAQ) ABVX

See If You Qualify For Monetary Reward

Join the ABIVAX Societe Anonyme Class Action Lawsuit

Abivax shareholders lost more than 40% of their investment value on June 2, 2026, as the stock plunged from a pre-announcement close of approximately $129.69 to as low as $71 per share midday after rare malignancy cases surfaced in the company's Phase 3 ABTECT ulcerative colitis trial for obefazimod. The market reaction was swift and severe. Trading volume surged to more than eight times the daily average on June 2. Jefferies downgraded ABVX from Buy to Hold and cut its price target from $160 to $90 -- a 43.75% reduction -- citing the cancer signal as a material overhang on the stock's outlook. Short interest climbed to approximately 12% of the float within 24 hours of the disclosure. Notably, the stock had initially rallied approximately 20% in after-hours trading on June 1 when the Phase 3 efficacy data were first released. Within hours, as the rare malignancy cases in the treatment arm received broader coverage, the rally reversed entirely and shares collapsed through the prior close. By the midday trading on June 2, ABVX had fallen more than 45%, erasing all gains since mid-August, 2025.

Frequently Asked Questions

How do I join the lawsuit against ABIVAX Societe Anonyme (NASDAQ: ABVX)?

Investors who purchased shares of ABIVAX Societe Anonyme (NASDAQ: ABVX) during the class period (June 2, 2021 - June 2, 2026) can join by submitting their transaction details through this case page.

Ensure your purchase falls within the class period
Provide basic transaction and loss details
Submit your information before the deadline

The lead plaintiff deadline for this case is To be determined, so investors should act quickly to protect their rights.

Who is eligible for the ABIVAX Societe Anonyme lawsuit?

Anyone who bought shares of ABIVAX Societe Anonyme (NASDAQ: ABVX) during June 2, 2021 - June 2, 2026 and suffered financial losses may qualify.

What is the lead plaintiff deadline to join the ABIVAX Societe Anonyme case?

The lead plaintiff deadline for the ABIVAX Societe Anonyme lawsuit is To be determined. Investors should act quickly to avoid missing this deadline.

What is the class period for ABIVAX Societe Anonyme?

The class period for ABIVAX Societe Anonyme (NASDAQ: ABVX) is June 2, 2021 - June 2, 2026, during which investors may have been affected by alleged misconduct.

Can I still join the ABIVAX Societe Anonyme lawsuit if I sold my shares?

Yes. Investors who purchased ABIVAX Societe Anonyme shares during June 2, 2021 - June 2, 2026 may still qualify, even if they sold their shares later.

How much compensation can I receive from the ABIVAX Societe Anonyme lawsuit?

Compensation depends on the total losses and the final settlement. Eligible investors in the ABIVAX Societe Anonyme case may receive a portion of the recovery.

Do I need to pay to participate in the ABIVAX Societe Anonyme case?

No, most securities fraud cases involving ABIVAX Societe Anonyme operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.

Will I need to appear in court for the ABIVAX Societe Anonyme lawsuit?

In most cases, investors do not need to appear in court. The legal team manages the ABIVAX Societe Anonyme case on behalf of participants.

What documents are required for the ABIVAX Societe Anonyme lawsuit?

To participate in the ABIVAX Societe Anonyme lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.

What happens after I submit my trade information for ABIVAX Societe Anonyme?

After submission, your details for the ABIVAX Societe Anonyme case will be reviewed, and you may be contacted regarding eligibility or next steps.

Is this legal advice for the ABIVAX Societe Anonyme lawsuit?

No, this page provides information about the ABIVAX Societe Anonyme case and does not constitute legal advice or create an attorney-client relationship.

Why should I act quickly on the ABIVAX Societe Anonyme case?

The lead plaintiff deadline for the ABIVAX Societe Anonyme lawsuit is To be determined. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.

EXPLORE MORE CASES

AeroVironment, Inc.

AVAV

Lead Plaintiff Deadline: July 27, 2026

Class Period: June 25, 2025 - March 10, 2026

44 Days Left

POET Technologies Inc.

POET

POET Technologies [POET] Securities Class Action Lawsuit Update

Lead Plaintiff Deadline: June 29, 2026

Class Period: April 1, 2026 - April 27, 2026

16 Days Left

FS KKR Capital Corp

FSK

FS KKR Capital Corp. (FSK) Securities Class Action Lawsuit Update

Lead Plaintiff Deadline: July 6, 2026

Class Period: May 8, 2024 - February 25, 2026

23 Days Left